These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 1719252

  • 1. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
    Huland E, Huland H, Meier T, Baricordi O, Fradet Y, Grossman HB, Hodges GM, Messing EM, Schmitz-Draeger BJ.
    J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
    [Abstract] [Full Text] [Related]

  • 2. Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
    Friedrich MG, Hellstern A, Hautmann SH, Graefen M, Conrad S, Huland E, Huland H.
    J Urol; 2002 Aug; 168(2):470-4. PubMed ID: 12131290
    [Abstract] [Full Text] [Related]

  • 3. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG, Hellstern A, Hautmann SH, Noldus I, Huland H.
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Monoclonal antibody 486 P 3/12: a valuable bladder carcinoma marker for immunocytology.
    Huland H, Arndt R, Huland E, Loening T, Steffens M.
    J Urol; 1987 Apr; 137(4):654-9. PubMed ID: 2435926
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunoreactivity of canine transitional cell carcinoma of the urinary bladder with monoclonal antibodies to tumor-associated glycoprotein 72.
    Clemo FA, DeNicola DB, Carlton WW, Walker E, Morrison WB.
    Vet Pathol; 1995 Mar; 32(2):155-61. PubMed ID: 7771056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.
    Zorzos J, Zizi A, Bakiras A, Pectasidis D, Skarlos DV, Zorzos H, Elemenoglou J, Likourinas M.
    Eur Urol; 1995 Mar; 28(3):251-4. PubMed ID: 8536781
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells.
    Bonner RB, Hemstreet GP, Fradet Y, Rao JY, Min KW, Hurst RE.
    Cancer; 1993 Oct 15; 72(8):2461-9. PubMed ID: 8402463
    [Abstract] [Full Text] [Related]

  • 12. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
    Summerhayes IC, McIlhinney RA, Ponder BA, Shearer RJ, Pocock RD.
    J Natl Cancer Inst; 1985 Dec 15; 75(6):1025-38. PubMed ID: 2415743
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma. I. Production, specificity analysis, and preliminary characterization of the antigen.
    Decken K, Schmitz-Dräger BJ, Rohde D, Nakamura S, Ebert T, Ackermann R.
    J Urol; 1992 Jan 15; 147(1):235-41. PubMed ID: 1729539
    [Abstract] [Full Text] [Related]

  • 14. Expression of Leu-M1 antigens in carcinoma of the urinary bladder.
    Hoshi S, Orikasa S, Numata I, Nose M.
    J Urol; 1986 May 15; 135(5):1075-7. PubMed ID: 3083124
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
    Ben-Aïssa H, Paulie S, Gustafsson B, Håkansson L, Lagerkvist M, Gustafson H, Ahlstrand C, Perlmann P.
    Anticancer Res; 1988 May 15; 8(3):443-9. PubMed ID: 3389746
    [Abstract] [Full Text] [Related]

  • 17. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H, Zhao Z, Sun H.
    Zhonghua Wai Ke Za Zhi; 1996 Sep 15; 34(9):560-2. PubMed ID: 9594163
    [Abstract] [Full Text] [Related]

  • 18. Expression of SSEA-1 (Lewis(x)) on transitional cell carcinoma of the bladder.
    Konety BR, Ballou B, Jaffe R, Singh J, Reiland J, Hakala TR.
    Urol Int; 1997 Sep 15; 58(2):69-74. PubMed ID: 9096265
    [Abstract] [Full Text] [Related]

  • 19. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
    Steffens J, Friedmann W, Lobeck H.
    Urol Res; 1985 Sep 15; 13(2):55-9. PubMed ID: 2409654
    [Abstract] [Full Text] [Related]

  • 20. Dual-parameter immunoflow cytometry in diagnosis and follow-up of patients with bladder cancer.
    Jankevicius F, Shibayama T, Decken K, Bojar H, Gerharz CD, Ebert T, Ackermann R, Schmitz-Dräger BJ.
    Eur Urol; 1998 Dec 15; 34(6):492-9. PubMed ID: 9831791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.